Attaching and Effacing Bacterial Effector NleC Suppresses Epithelial Inflammatory Responses by Inhibiting NF-κB and p38 Mitogen-Activated Protein Kinase Activation
- 1 September 2011
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 79 (9) , 3552-3562
Abstract
Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli are noninvasive attaching and effacing (A/E) bacterial pathogens that cause intestinal inflammation and severe diarrheal disease. These pathogens utilize a type III secretion system to deliver effector proteins into host epithelial cells, modulating diverse cellular functions, including the release of the chemokine interleukin-8 (IL-8). While studies have implicated the effectors NleE (non-locus of enterocyte effacement [LEE]-encoded effector E) and NleH1 in suppressing IL-8 release, by preventing NF-κB nuclear translocation, the impact of these effectors only partially replicates the immunosuppressive actions of wild-type EPEC, suggesting another effector or effectors are involved. Testing an array of EPEC mutants, we identified the non-LEE-encoded effector C (NleC) as also suppressing IL-8 release. Infection by Δ nleC EPEC led to exaggerated IL-8 release from infected Caco-2 and HT-29 epithelial cells. NleC localized to EPEC-induced pedestals, with signaling studies revealing NleC inhibits both NF-κB and p38 mitogen-activated protein kinase (MAPK) activation. Using Citrobacter rodentium , a mouse-adapted A/E bacterium, we found that Δ nleC and wild-type C. rodentium -infected mice carried similar pathogen burdens, yet Δ nleC strain infection led to worsened colitis. Similarly, infection with Δ nleC C. rodentium in a cecal loop model induced significantly greater chemokine responses than infection with wild-type bacteria. These studies thus advance our understanding of how A/E pathogens subvert host inflammatory responses.Keywords
This publication has 57 references indexed in Scilit:
- IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7Nature Immunology, 2011
- A type III effector protease NleC from enteropathogenic Escherichia coli targets NF‐κB for degradationMolecular Microbiology, 2011
- Proteasome-independent Degradation of Canonical NFκB Complex Components by the NleC Protein of Pathogenic Escherichia coliJournal of Biological Chemistry, 2011
- Metalloprotease type III effectors that specifically cleave JNK and NF‐κBThe EMBO Journal, 2010
- Novel Changes in NF-κB Activity during Progression and Regression Phases of HyperplasiaJournal of Biological Chemistry, 2010
- Gut inflammation provides a respiratory electron acceptor for SalmonellaNature, 2010
- Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasomeProceedings of the National Academy of Sciences, 2010
- A Comprehensive Proteomic Analysis of the Type III Secretome of Citrobacter rodentiumJournal of Biological Chemistry, 2010
- The effector repertoire of enteropathogenic E. coli: ganging up on the host cellCurrent Opinion in Microbiology, 2009
- War and peace at mucosal surfacesNature Reviews Immunology, 2004